This comprehensive guide explores the use of Receiver Operating Characteristic (ROC) curves and Area Under the Curve (AUC) for evaluating biomarker discrimination in biomedical research.
This review synthesizes current research on the critical role of IFNγ signaling pathway integrity in determining patient response to immune checkpoint inhibitors (ICIs).
This definitive guide provides researchers, scientists, and drug development professionals with a comprehensive framework for successful immunohistochemistry (IHC) detection of Cancer Stem Cell (CSC) biomarkers.
This review synthesizes current research on the spatial and compositional heterogeneity of the immune tumor microenvironment (TME) between primary tumors and their distant metastases.
This article provides a comprehensive analysis of the immune checkpoint molecules PD-L1 and Siglec-15 within the tumor microenvironment (TME).
This article provides a comprehensive analysis of contemporary combination therapy strategies involving immune checkpoint inhibitors (ICIs), tailored for researchers and drug development professionals.
This comprehensive guide explores the critical role of ISO standards in establishing robust, reliable, and globally harmonized organoid biobanks.
This article provides a detailed analysis of the International Society of Liquid Biopsy (ISLB) standards for circulating tumor DNA (ctDNA) testing.
This comprehensive guide provides researchers and drug development professionals with an up-to-date, detailed protocol for immunohistochemical (IHC) detection of key non-small cell lung cancer (NSCLC) biomarkers: ALK, ROS1, and EGFR.
This article provides a comprehensive analysis of IDO (Indoleamine 2,3-dioxygenase) inhibition as a strategic approach to combat resistance to immune checkpoint blockade (ICB) therapies like anti-PD-1/PD-L1.